SLE (SYSTEMIC LUPUS)
Clinical trials for SLE (SYSTEMIC LUPUS) explained in plain language.
Never miss a new study
Get alerted when new SLE (SYSTEMIC LUPUS) trials appear
Sign up with your email to follow new studies for SLE (SYSTEMIC LUPUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental CAR-T therapy takes on tough lupus kidney cases
Disease control Not yet recruitingThis study tests a new treatment called CRC01 for people with severe lupus that has caused kidney damage (lupus nephritis). CRC01 is made from the patient's own immune cells, which are modified to target and calm the overactive immune system. The trial will enroll 39 adults who h…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1, PHASE2 • Sponsor: Curocell Inc. • Aim: Disease control
Last updated May 26, 2026 09:32 UTC
-
New drug ISH0613 tested in humans for first time
Knowledge-focused Not yet recruitingThis early-stage study tests a new drug called ISH0613 in 26 healthy adults to see if it is safe and how the body handles it. Participants get a single dose of the drug or a placebo and are closely monitored for side effects. The results will help guide future research in conditi…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC